0001950047-23-003178.txt : 20230816 0001950047-23-003178.hdr.sgml : 20230816 20230816163350 ACCESSION NUMBER: 0001950047-23-003178 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230816 DATE AS OF CHANGE: 20230816 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 231178652 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Agresta Samuel CENTRAL INDEX KEY: 0001748961 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 784 MEMORIAL DR. CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001748961 XXXXXXXX LIVE 0001822462 FOGHORN THERAPEUTICS INC 001-39634 500 Technology Square, Ste 700 Cambridge MA 02139 617-586-3100 SAMUEL AGRESTA Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

311297 2568200.25 41862174 08/16/2023 NASDAQ Common 08/16/2023 Exercise of options under a registered plan Issuer N 311297 08/16/2023 Cash Y 08/16/2023 /s/ Samuel Agresta